menu
    • menu

    Company profile for Enveric Biosciences

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions t...
    Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric's robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enveric BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4851 Tamiami Trail N, Suite 200 Naples, FL 34103
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enveric.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/envericbio/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Enveric_Bio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enveric Biosciences Granted Notice Of Allowance For EVM301 Drug
    Enveric Biosciences Granted Notice Of Allowance For EVM301 Drug

    09 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-09/enveric-biosciences-receives-notice-of-allowance-for-evm301-series-of-drug-candidates

    PHARMIWEB
    09 Dec 2025
    Share Share
    Enveric Biosciences To Join Panel At Sachs Neuroscience
    Enveric Biosciences To Join Panel At Sachs Neuroscience

    04 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251204301713/en/Enveric-Biosciences-to-Present-at-and-Participate-in-Panel-Discussion-at-Sachs-Associates-9th-Annual-Neuroscience-Innovation-Forum-During-J.P.-Morgan-Week-2026

    BUSINESSWIRE
    04 Dec 2025
    Share Share
    Enveric Biosciences Granted Fourth Notice Of Allowance for EVM401
    Enveric Biosciences Granted Fourth Notice Of Allowance for EVM401

    26 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251121013838/en/Enveric-Biosciences-Receives-Fourth-Notice-of-Allowance-for-EVM401-Series-of-Drug-Candidates

    BUSINESSWIRE
    26 Nov 2025
    Share Share
    Enveric Biosciences Unveils Q3 2025 Financial Result Outcomes
    Enveric Biosciences Unveils Q3 2025 Financial Result Outcomes

    14 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113113066/en/Enveric-Biosciences-Reports-Third-Quarter-2025-Financial-and-Corporate-Results

    BUSINESSWIRE
    14 Nov 2025
    Share Share
    Enveric Biosciences Announces Reverse Stock Split
    Enveric Biosciences Announces Reverse Stock Split

    23 Oct 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251023433331/en/Enveric-Biosciences-Announces-Reverse-Stock-Split

    BUSINESS WIRE
    23 Oct 2025
    Share Share
    Enveric Biosciences Strengthens Ip Portfolio With New U.S. Patent
    Enveric Biosciences Strengthens Ip Portfolio With New U.S. Patent

    16 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-16/enveric-biosciences-further-enhances-intellectual-property-estate-with-new-us-patent-issuance

    PHARMIWEB
    16 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search